Long-term treatment with extended-release carbidopa-levodopa (IPX066) in early and advanced Parkinson's disease: A 9-month open-label extension trial

Cheryl H. Waters*, Paul Nausieda, Lyudmila Dzyak, Joerg Spiegel, Monika Rudzinska, Dee E. Silver, Elena S. Tsurkalenko, Sherron Kell, Ann Hsu, Sarita Khanna, Suneel Gupta

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term treatment with extended-release carbidopa-levodopa (IPX066) in early and advanced Parkinson's disease: A 9-month open-label extension trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science